Cargando…
Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6‐OHDA model of Parkinson's disease
AIMS: Experimental and clinical evidences demonstrate that common dysregulated pathways are involved in Parkinson’s disease (PD) and type 2 diabetes. Recently, insulin treatment through intranasal (IN) approach has gained attention in PD, although the underlying mechanism of its potential therapeuti...
Autores principales: | Iravanpour, Farideh, Dargahi, Leila, Rezaei, Mohsen, Haghani, Masoud, Heidari, Reza, Valian, Neda, Ahmadiani, Abolhassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871791/ https://www.ncbi.nlm.nih.gov/pubmed/33497031 http://dx.doi.org/10.1111/cns.13609 |
Ejemplares similares
-
Does Repeated Methamphetamine Exposure at Different Regimens Cause Parkinsonian-Like Behavior in Rats?
por: Valian, Neda, et al.
Publicado: (2018) -
Comparison of Rat Primary Midbrain Neurons Cultured in DMEM/F12 and Neurobasal Mediums
por: Valian, Neda, et al.
Publicado: (2021) -
Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
por: Salari, Mehri, et al.
Publicado: (2022) -
Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022) -
Mitochondrial Complex I Is an Essential Player in LPS-Induced Preconditioning in Differentiated PC12 Cells
por: Manouchehri, Nasim, et al.
Publicado: (2019)